The molecular analysis of muscle—CHRNA1, RYR1, and TTN—and muscle-like—NEFM, RYR3, and HSP60—autoantigen gene expression provides new insights in the intra-thymic alterations underlying autosensitization to muscle autoantigens in AChR-MG patients. This evidence concerns the gene RYR1 and myasthenia gravis.